Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an online course help you live better with chronic disease?

NCT ID NCT06484322

Symptom relief Sponsor: Luleå Tekniska Universitet Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a new internet-based program called SEE 2.0, designed to help people with chronic diseases like long-term pain, fatigue, or lung conditions manage their daily activities better. Researchers will enroll 40 adults aged 18-75 who struggle with everyday tasks. The program includes educational videos and self-reflection exercises to improve satisfaction, balance, and value in daily life. This is a small feasibility study to see if the approach works and can be used more widely.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
internet-based occupational therapy program (Strategies Empowering Activities in Everyday Life 2.0)
What this could lead to
If it works, this could offer a practical, home-based way for people with chronic conditions to feel more satisfied and balanced in their daily lives.
What could go wrong
This is a small feasibility study with only 40 participants, so results may not apply widely. The program requires self-motivation and internet access, which may limit its usefulness for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosed with, or at risk of developing, a chronic disease/long-term condition such as long-term pain, stress-related conditions, chronic fatigue syndrome, rheumatological diseases, lung diseases, or neurological conditions. * Age: 18-75 years * Experiencing difficulties to have an active everyday life and/or experiencing a need to develop self-management strategies in everyday life. * Have access to a screen/computer, internet and e-ID as well as being able to use them * Be able to participate in the program, including be ready for a process of change * Understanding of the Swedish language in written and oral form. Exclusion Criteria: * Sickness or disease which causes difficulties with understanding written and verbal advice (e.g. mental or cognitive illness). * Having an ongoing misuse * Receiving palliative care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic disease

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Luleå University of Technology

    NOT_YET_RECRUITING

    Luleå, 97187, Sweden

  • Luleå university of technology

    RECRUITING

    Luleå, None Selected, 971 87, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.